NovaSure Endometrial Ablation

NovaSure Endometrial Ablation (EA) is a one-time, 5-minute procedure that can lighten or end your heavy period. No pills. No hormonal side effects. All of our physicians offer this procedure.

For 90% of women, menstrual bleeding is dramatically reduced or stopped. It’s a simple procedure that can be done in our office, usually for the cost of a copay.

NovaSure benefits

• One-time procedure
• The procedure is quick—it usually takes less than five minutes
• It can be performed in a doctor’s office with no general anesthesia
• 90% of women returned to normal, light or no periods at all¹
• 40% reported that their periods stopped completely¹
• Most women experience mild or no pain during or after the procedure²
• Most women feel back to themselves within a day or so¹
• There are no incisions (an incision is a cut into your body)
• It can be performed at any time during your cycle, even if you’re bleeding
• You don’t need to prepare by taking any pre-treatment medicine

What you need to know

NovaSure is for premenopausal women with heavy periods due to benign causes who are finished childbearing. Pregnancy following NovaSure can be dangerous. NovaSure is not for those who have or suspect uterine cancer, have an active genital, urinary or pelvic infection, an IUD or a metal uterine implant. Rare but serious risks include thermal injury, perforation, infection and other problems. Temporary side effects may include cramping, nausea, vomiting, discharge and spotting. Talk to your doctor for more information. NovaSure is not a sterilization procedure and not for women who may be pregnant.

Your doctor can explain the various treatment options for heavy periods and help you decide if NovaSure® is right for you.

1. Cooper J, et al. A randomized, multicenter trial of safety and efficacy of the NovaSure system in the treatment of menorrhagia. J Am Assoc Gynecol Laparosc. 2002; 9:418-428.
2. Backman T, Huhtala S, Blom T, Luoto R, Rauramo I, Koskenvuo M. Length of use and symptoms associated with premature removal of levonorgestrel intrauterine system: a nation-wide study of 17,360 users. BJOG 2000; 107:335-9.